A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer.

D. Kaufman,M. Carducci,T. Kuzel,M. Todd,W. Oh,Matthew R. Smith,Z. Ye,S. Nicol,W. Stadler
DOI: https://doi.org/10.1016/J.UROLONC.2004.01.002
2004-09-01
Abstract:
What problem does this paper attempt to address?